These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

864 related items for PubMed ID: 21699452

  • 1. Effects of multiple factorial intervention on ambulatory BP profile and renal function in hypertensive type 2 diabetic patients with overt nephropathy - a pilot study.
    Kanaoka T, Tamura K, Moriya T, Tanaka K, Konno Y, Kondoh S, Toyoda M, Umezono T, Fujikawa T, Ohsawa M, Dejima T, Maeda A, Wakui H, Haku S, Yanagi M, Mitsuhashi H, Ozawa M, Okano Y, Ogawa N, Yamakawa T, Mizushima S, Suzuki D, Umemura S.
    Clin Exp Hypertens; 2011; 33(4):255-63. PubMed ID: 21699452
    [Abstract] [Full Text] [Related]

  • 2. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H, Kanno Y, Nakamoto H, Okada H, Sugahara S.
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [Abstract] [Full Text] [Related]

  • 3. Morning home blood pressure may be a significant marker of nephropathy in Japanese patients with type 2 diabetes: ADVANCED-J study 1.
    Tanaka Y, Daida H, Imai Y, Miyauchi K, Sato Y, Hiwatari M, Kitagawa A, Kishimoto J, Yamazaki T, Kawamori R.
    Hypertens Res; 2009 Sep; 32(9):770-4. PubMed ID: 19557003
    [Abstract] [Full Text] [Related]

  • 4. Effects of angiotensin II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathy.
    Masuda S, Tamura K, Wakui H, Kanaoka T, Ohsawa M, Maeda A, Dejima T, Yanagi M, Azuma K, Umemura S.
    Hypertens Res; 2009 Nov; 32(11):950-5. PubMed ID: 19713965
    [Abstract] [Full Text] [Related]

  • 5. Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes.
    Estacio RO, Coll JR, Tran ZV, Schrier RW.
    Am J Hypertens; 2006 Dec; 19(12):1241-8. PubMed ID: 17161769
    [Abstract] [Full Text] [Related]

  • 6. Factors determining the 24-h blood pressure profile in normotensive patients with type 1 and type 2 diabetes.
    Spallone V, Maiello MR, Cicconetti E, Pannone A, Barini A, Gambardella S, Menzinger G.
    J Hum Hypertens; 2001 Apr; 15(4):239-46. PubMed ID: 11319671
    [Abstract] [Full Text] [Related]

  • 7. Ambulatory blood pressure and heart rate in hypertensives with renal failure: comparison between diabetic nephropathy and non-diabetic glomerulopathy.
    Tamura K, Yamauchi J, Tsurumi-Ikeya Y, Sakai M, Ozawa M, Shigenaga A, Azuma K, Okano Y, Ishigami T, Toya Y, Yabana M, Tokita Y, Ohnishi T, Umemura S.
    Clin Exp Hypertens; 2008 Jan; 30(1):33-43. PubMed ID: 18214732
    [Abstract] [Full Text] [Related]

  • 8. Ambulatory blood pressure variability is increased in diabetic hypertensives.
    Ozawa M, Tamura K, Iwatsubo K, Matsushita K, Sakai M, Tsurumi-Ikeya Y, Azuma K, Shigenaga A, Okano Y, Masuda S, Wakui H, Ishigami T, Umemura S.
    Clin Exp Hypertens; 2008 Apr; 30(3):213-24. PubMed ID: 18425701
    [Abstract] [Full Text] [Related]

  • 9. The bedtime administration of doxazosin controls morning hypertension and albuminuria in patients with type-2 diabetes: evaluation using home-based blood pressure measurements.
    Kamoi K, Ikarashi T.
    Clin Exp Hypertens; 2005 May; 27(4):369-76. PubMed ID: 15921073
    [Abstract] [Full Text] [Related]

  • 10. Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study.
    Astrup AS, Nielsen FS, Rossing P, Ali S, Kastrup J, Smidt UM, Parving HH.
    J Hypertens; 2007 Dec; 25(12):2479-85. PubMed ID: 17984670
    [Abstract] [Full Text] [Related]

  • 11. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.
    Bakris GL, Weir MR, Shanifar S, Zhang Z, Douglas J, van Dijk DJ, Brenner BM, RENAAL Study Group.
    Arch Intern Med; 2003 Jul 14; 163(13):1555-65. PubMed ID: 12860578
    [Abstract] [Full Text] [Related]

  • 12. Effects of doxazosin on ambulatory blood pressure and sympathetic nervous activity in hypertensive Type 2 diabetic patients with overt nephropathy.
    Yasuda G, Hasegawa K, Kuji T, Ogawa N, Shimura G, Umemura S, Tochikubo O.
    Diabet Med; 2005 Oct 14; 22(10):1394-400. PubMed ID: 16176202
    [Abstract] [Full Text] [Related]

  • 13. Office and ambulatory pulse pressure--association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study).
    Januszewicz A, Ritz E, Viberti G, Mimran A, Rabelink AJ, Rump LC, Ruilope LM, Katayama S, Ito S, Izzo JL, Haller H.
    J Hum Hypertens; 2011 Nov 14; 25(11):679-85. PubMed ID: 21150933
    [Abstract] [Full Text] [Related]

  • 14. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
    Salako BL, Finomo FO, Kadiri S, Arije A, Olatosin AO.
    Afr J Med Med Sci; 2002 Mar 14; 31(1):53-7. PubMed ID: 12518931
    [Abstract] [Full Text] [Related]

  • 15. A possible relationship of nocturnal blood pressure variability with coronary artery disease in diabetic nephropathy.
    Tamura K, Tsurumi Y, Sakai M, Tanaka Y, Okano Y, Yamauchi J, Ishigami T, Kihara M, Hirawa N, Toya Y, Yabana M, Tokita Y, Ohnishi T, Umemura S.
    Clin Exp Hypertens; 2007 Jan 14; 29(1):31-42. PubMed ID: 17190729
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
    Minutolo R, Gabbai FB, Borrelli S, Scigliano R, Trucillo P, Baldanza D, Laurino S, Mascia S, Conte G, De Nicola L.
    Am J Kidney Dis; 2007 Dec 14; 50(6):908-17. PubMed ID: 18037091
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes.
    Moyá A, Crespo JJ, Ayala DE, Ríos MT, Pousa L, Callejas PA, Salgado JL, Mojón A, Fernández JR, Hermida RC, Hygia Project Investigators.
    Chronobiol Int; 2013 Mar 14; 30(1-2):116-31. PubMed ID: 23181613
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.